Axis-Shield suffers knock-back in homocysteine case
This article was originally published in Clinica
Executive Summary
Axis-Shield has voiced its disappointment over a ruling by a US district court to fast-track a patent litigation case which the Dundee, Scotland-based diagnostics firm filed against General Atomics (GA), a company whose enzymatic test for homocysteine is claimed to infringe on Axis-Shield's US patents.